✦ LIBER ✦

Reduction in ultra-sensitive C-reactive protein levels and regression of intima media thickness with high and low doses atorvastatin in patients with primary hypercholesterolaemia

Book ID: 118631051
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 144 KB
Volume: 3
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(02)80497-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bilirubin Levels and Their Association w

Bilirubin Levels and Their Association with Carotid Intima Media Thickness and High-Sensitivity C-reactive Protein in Patients with Psoriasis Vulgaris

✍ Balta, Sevket; Balta, Ilknur; Mikhailidis, Dimitri P.; Ozturk, Cengiz; Demirkol, 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 243 KB

OP-333 Bilirubin Levels and their Associ

OP-333 Bilirubin Levels and their Association with Carotid Intima Media Thickness and High-Sensitivity C-Reactive Protein in Patients with Psoriasis Vulgaris

✍ Balta, S.; Balta, I.; Mikhailidis, D.P.; Demirkol, S.; Celik, T.; Ozturk, C.; De 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Attainment of Dual Treatment Levels for

Attainment of Dual Treatment Levels for High-Sensitivity C-Reactive Protein and Lipids in Older (>65 Years) Patients with Cardiovascular Disease Risk: Ezetimibe/Simvastatin Versus Atorvastatin

✍ Franklin Joseph Zieve; W. Virgil Brown; JoAnne M. Foody; Charlotte Jones-Burton; 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 41 KB

Rosuvastatin in the Primary Prevention o

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Rationale and Design of the JUPITER Trial*

✍ Ridker, P. M 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 427 KB

Achievement of specified low-density lip

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 469 KB

Effects of Ezetimibe Added to Atorvastat

Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk

✍ Christian Constance; Ori Ben-Yehuda; Nanette K. Wenger; Franklin Zieve; Jianxin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 50 KB